CVS Health Corporation (CVS) - NYSE
  • May 1, 2013, 7:05 AM
    CVS Caremark (CVS): Q1 EPS of $0.83 beats by $0.03. Revenue of $30.7B beats by $0.34B. (PR)
    | May 1, 2013, 7:05 AM
  • May 1, 2013, 12:05 AM
    Notable earnings before Wednesday’ s open: AB, ADT, AFAM, AFSI, AGN, AH, AMT, ARW, AVA, CCJ, CHK, CLH, CLX, CMCSA, CVH, CVS, DLPH, DVN, ENR, EXAS, EXC,GRMN, GWR, H, HSP, HUM, ICE, IPGP, IQNT, IRM, JRCC, KCG, KFN, MA, MKL, MRK, NVO, PDCE, PKD, POR, PSX, RDC, RDN, SEE, SPW, TLM, TWX, VG, VIAB, VPHM
    | May 1, 2013, 12:05 AM
  • Apr. 30, 2013, 5:30 PM
    Notable earnings before Wednesday’ s open: AB, ADT, AFAM, AFSI, AGN, AH, AMT, ARW, AVA, CCJ, CHK, CLH, CLX, CMCSA, CVH, CVS, DLPH, DVN, ENR, EXAS, EXC,GRMN, GWR, H, HSP, HUM, ICE, IPGP, IQNT, IRM, JRCC, KCG, KFN, MA, MKL, MRK, NVO, PDCE, PKD, POR, PSX, RDC, RDN, SEE, SPW, TLM, TWX, VG, VIAB, VPHM
    | Apr. 30, 2013, 5:30 PM
  • Apr. 30, 2013, 10:04 AM

    A combined read of Redbook and ICSCS-Goldman's data on chain store sales indicates the late start to the spring season could take its toll on apparel sellers. Despite the choppy start to Q2, chain-store sales are still heading for a 2%-3% gain during the month compared to last year. Possible April winners: Drugstores [Walgreen (WAG), Rite Aid (RAD), CVS Caremark (CVS)] and wholesale clubs [Costco (COST), PriceSmart (PSMT), BJ's Wholesale].

    | Apr. 30, 2013, 10:04 AM
  • Apr. 7, 2013, 9:00 AM

    With their healthcare costs ballooning, many companies have started to penalize fat employees with regards to healthcare coverage, raising all sorts of legal, privacy and discrimination questions. Michelin North America, for example, plans to cut healthcare credits for staff who fail to meet requirement for waistline and other metrics, and don't sign up to health programs. Other companies making similar moves include Mohawk (MHK), CVS and Honeywell (HON).

    | Apr. 7, 2013, 9:00 AM | 60 Comments
  • Apr. 4, 2013, 12:51 PM

    Health experts forecast this season's allergy season will be extremely harsh. As a result, drug store chains such as Rite Aid (RAD -3.7%), CVS Caremark (CVS +1.9%), and Walgreen (WAG +0.4%) are expecting a mild bounce in April store traffic due to the development. (Previous on March sales: WAG, RAD)

    | Apr. 4, 2013, 12:51 PM
  • Mar. 28, 2013, 9:18 AM

    Look for a new report from Consumer Reports on the cost of prescription drugs at retail chains to create some buzz. Analysis by the publication shows that consumers can save as much as $100 a month by comparison shopping. Costco (COST) came in the low end of the scale for generic drug prices while CVS Caremark (CVS) was the highest. Drugstore chains (WAG, RAD) could face increasing pricing pressure with big box retailers more willing to use low prices at their pharmacies as a traffic driver.

    | Mar. 28, 2013, 9:18 AM | 4 Comments
  • Mar. 6, 2013, 3:47 PM
    CVS Caremark Corporation (CVS) declares $0.225/share quarterly dividend, in line with previous. Forward yield 1.72%. For shareholders of record Apr. 23. Payable May 03. Ex-div date Apr. 19. (PR)
    | Mar. 6, 2013, 3:47 PM
  • Mar. 1, 2013, 7:14 AM

    Drugstore chains (WAG, CVS, RAD) continue to push further into healthcare to make up for lagging prescription drug sales. The latest development is an initiative by Rite Aid to open 58 stores which have in-store clinics where customers can interact with a doctor using a Web cam. Customers in Baltimore, Boston, Philadelphia, and Pittsburgh can pay $45 for a 10-minute consult with a doctor via a PC.

    | Mar. 1, 2013, 7:14 AM | 6 Comments
  • Feb. 19, 2013, 12:37 PM

    CVS Caremark (CVS +2.6%) and Rite Aid (RAD +5.4%) both trade higher, riding the back of a strong quarter and promising guidance from Express Scripts. Sector peer Walgreen (WAG +0.9%) isn't quite keeping up despite a price target boost by Cantor Fitzgerald to $45.

    | Feb. 19, 2013, 12:37 PM | 2 Comments
  • Feb. 11, 2013, 2:21 PM
    After seeing the number of flu shots administered skyrocket this year to boost revenue, drug store operators such as Walgreen (WAG +0.1%) and CVS Caremark (CVS +0.1%) want to expand past flu shots to offer a full range of immunizations and additional healthcare services. For the sector to gets its way, states will have to expand the powers of pharmacists, a development that stands a decent chance of coming off because it saves employers money.
    | Feb. 11, 2013, 2:21 PM | 1 Comment
  • Feb. 6, 2013, 7:18 AM

    More on CVS Caremark's (CVS) Q4: Revenue in the Retail Pharmacy segment rose 5.1% to $16.3B as higher traffic more than offset the impact of new generic introductions. An effective tax rate and share count that were lower than anticipated contributed to the EPS beat. The company sees FY13 EPS of $3.86-$4.00, roughly in-line with the consensus estimate of analysts calling for $3.94. (PR)

    | Feb. 6, 2013, 7:18 AM
  • Feb. 6, 2013, 7:01 AM
    CVS Caremark (CVS): Q4 EPS of $1.14 beats by $0.03. Revenue of $31.4B (+10.9% Y/Y) beats by $0.27B. (PR)
    | Feb. 6, 2013, 7:01 AM
  • Feb. 6, 2013, 12:05 AM

    Notable earnings before Wednesday’s open: ABMD, AINV, CMI, CMP, CVH, CVS, ELN, GAS, ICE, IVR, MPEL, MRO, MT, NUS, PLD, RL, TWX, USG, VICL, VMED

    | Feb. 6, 2013, 12:05 AM
  • Feb. 5, 2013, 5:30 PM

    Notable earnings before Wednesday’s open: ABMD, AINV, CMI, CMP, CVH, CVS, ELN, GAS, ICE, IVR, MPEL, MRO, MT, NUS, PLD, RL, TWX, USG, VICL, VMED

    | Feb. 5, 2013, 5:30 PM
  • Jan. 30, 2013, 10:48 AM

    CVS Caremark (CVS +0.6%) continues to draw attention from investment managers as it retains more customers added on during the Express Scripts-Walgreen dispute than anticipated and sees increased traffic into its stores due to the national flu epidemic. Despite a 7% YTD run already, share could move even higher if Q4 numbers come in strong.

    | Jan. 30, 2013, 10:48 AM
Company Description
CVS Health Corp. is integrated pharmacy health care provider in the U.S. The company reinvents pharmacy for better health and develops new ways to improve access for patients, promote better health outcomes and control payor costs in a way that no pharmacy retailer or PBM could do separately. It... More
Sector: Healthcare
Industry: Drug Stores
Country: United States